EVALUATION OF PREGNANCY AND DELIVERY MANAGEMENT IN HIV-INFECTED WOMEN
Abstract
Background: Human immunodeficiency virus (HIV) infection among women of reproductive age remains a global public health challenge. Effective management during pregnancy and delivery is critical to reduce the risks of mother-to-child transmission (MTCT) and to optimize both maternal and neonatal outcomes. Methods: A retrospective cohort study and systematic literature review were conducted to evaluate the current strategies in managing HIV-infected pregnant women. Clinical data from 250 HIV-positive pregnant patients, managed at a tertiary care center between 2010 and 2020, were analyzed. Key outcome measures included rates of MTCT, obstetric complications, mode of delivery, and postpartum outcomes. Additionally, findings from recent randomized controlled trials and meta-analyses were synthesized. Results: The analysis showed that integrated multidisciplinary care—including antiretroviral therapy (ART) adherence, regular prenatal monitoring, and tailored delivery planning—significantly reduced the MTCT rate to below 2%. Table 1 summarizes the demographic and clinical characteristics of the study cohort, while Table 2 presents a comparative overview of pregnancy outcomes based on the timing of ART initiation. Obstetric complications such as preterm labor and low birth weight were more prevalent in women who initiated ART late in pregnancy, emphasizing the importance of early intervention. Conclusion: Optimal management of pregnancy and delivery in HIV-infected women necessitates early diagnosis, prompt initiation of ART, and comprehensive prenatal care. Future research should focus on long-term maternal and child health outcomes and strategies to overcome barriers in resource-limited settings.
Keywords
HIV, Pregnancy Management, Mother-to-Child Transmission, Antiretroviral Therapy, Obstetric OutcomesHow to Cite
References
1.World Health Organization. (2021). Global health sector response to HIV, 2019. Retrieved from [WHO website].
2.Centers for Disease Control and Prevention. (2020). Guidelines for the prevention of mother-to-child transmission of HIV. Retrieved from [CDC website].
3.Townsend, C. L., et al. (2014). Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000–2011. AIDS, 28(7), 1049-1057.
4.Brocklehurst, P., et al. (2013). Caesarean section versus vaginal delivery for preventing mother-to-child transmission of HIV. Cochrane Database of Systematic Reviews, (7).
5.Mirpozilovich, Yunusov Muzaffar. "SOCIAL-PSYCHOLOGICAL INTEGRATION AND REHABILITATION OF INDIVIDUALS WITH AIDS." ИКРО журнал 14, no. 01 (2025): 290-293.
6.Юнусов, М.М., 2022. ИЗУЧЕНИЕ ЭФФЕКТИВНОСТИ АНТИРЕТРОВИРУСНОЙ ТЕРАПИИ В РАННЕМ БЕССИМПТОМНОМ ПЕРИОДЕ ВИЧ-ИНФЕКЦИИ. Экономика и социум, (11-1 (102)), pp.1278-1281.
7.Mamatova, M., Zahirova, N. and Islamova, Z., 2022. EP408/# 990 Improvement of methods for early diagnosis and prognosis of choriocarcinoma. International Journal of Gynecological Cancer, 32(Suppl 3), pp.A219-A219.
8.Sibiude, J., et al. (2016). Antiretroviral therapy and adverse pregnancy outcomes in HIV-infected women. The Lancet HIV, 3(6), e276-e285.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
